Please use this identifier to cite or link to this item: http://dx.doi.org/10.14279/depositonce-6934
Main Title: Chip-based human liver-intestine and liver-skin co-culture
Subtitle: A first step toward systemic repeated dose substance testing in vitro
Author(s): Maschmeyer, Ilka
Hasenberg, Tobias
Jaenicke, Annika
Lindner, Marcus
Lorenz, Alexandra Katharina
Zech, Julie
Garbe, Leif-Alexander
Sonntag, Frank
Hayden, Patrick
Ayehunie, Seyoum
Lauster, Roland
Marx, Uwe
Materne, Eva-Maria
Type: Article
Language Code: en
Abstract: Systemic repeated dose safety assessment and systemic efficacy evaluation of substances are currently carried out on laboratory animals and in humans due to the lack of predictive alternatives. Relevant international regulations, such as OECD and ICH guidelines, demand long-term testing and oral, dermal, inhalation, and systemic exposure routes for such evaluations. So-called “human-on-a-chip” concepts are aiming to replace respective animals and humans in substance evaluation with miniaturized functional human organisms. The major technical hurdle toward success in this field is the life-like combination of human barrier organ models, such as intestine, lung or skin, with parenchymal organ equivalents, such as liver, at the smallest biologically acceptable scale. Here, we report on a reproducible homeostatic long-term co-culture of human liver equivalents with either a reconstructed human intestinal barrier model or a human skin biopsy applying a microphysiological system. We used a multi-organ chip (MOC) platform, which provides pulsatile fluid flow within physiological ranges at low media-to-tissue ratios. The MOC supports submerse cultivation of an intact intestinal barrier model and an air–liquid interface for the skin model during their co-culture with the liver equivalents respectively at 1/100.000 the scale of their human counterparts in vivo. To increase the degree of organismal emulation, microfluidic channels of the liver–skin co-culture could be successfully covered with human endothelial cells, thus mimicking human vasculature, for the first time. Finally, exposure routes emulating oral and systemic administration in humans have been qualified by applying a repeated dose administration of a model substance – troglitazone – to the chip-based co-cultures.
URI: https://depositonce.tu-berlin.de//handle/11303/7756
http://dx.doi.org/10.14279/depositonce-6934
Issue Date: 2015
Date Available: 7-May-2018
DDC Class: 610 Medizin und Gesundheit
Subject(s): human barrier models
intestine model
skin equivalent
3D tissue culture
organ-on-a-chip
human-on-a-chip
microphysiological system
alternatives to animal testing
vasculature
systemic drug testing
Sponsor/Funder: BMBF/0315569/GO-Bio 3: Multi-Organ-Bioreaktoren für die prädiktive Substanztestung im Chipformat
License: https://creativecommons.org/licenses/by-nc-nd/4.0/
Journal Title: European Journal of Pharmaceutics and Biopharmaceutics
Publisher: Elsevier
Publisher Place: Amsterdam
Volume: 95 (A)
Publisher DOI: 10.1016/j.ejpb.2015.03.002
Page Start: 77
Page End: 87
ISSN: 0939-6411
Appears in Collections:FG Medizinische Biotechnologie » Publications

Files in This Item:
File Description SizeFormat 
1-s2.0-S0939641115001332-main.pdf2.27 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons